TrialInternational journal of hematology2014

Efficacy and safety of dasatinib versus imatinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia (CML-CP): Subset analysis of the DASISION trial with 2-year follow-up.

Shin Fujisawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.